Thomas Schreier

Drug persistence with rivaroxaban therapy in atrial fibrillation patients—results from the Dresden non-interventional oral anticoagulation registry

J. Beyer-Westendorf, N. Weiss, Vera Gelbricht, 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry.

J. Beyer-Westendorf, S. Werth, E. Kuhlisch, 2014, British journal of clinical pharmacology.

Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs

J. Beyer-Westendorf, S. Marten, Julia Goetze, 2017, Journal of Gastroenterology.

Real Life Efficacy and Safety of Rivaroxaban for Acute VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

J. Beyer-Westendorf, S. Werth, Vera Gelbricht, 2012 .

Rates, management and outcome of bleeding complications during edoxaban therapy in daily care - results from the DRESDEN NOAC REGISTRY.

M. Bornhäuser, J. Beyer-Westendorf, S. Marten, 2020, Thrombosis research.

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119)

J. Beyer-Westendorf, S. Werth, Franziska Ebertz, 2012 .